sublingual delivery glp-1 receptor agonists of Human Loaded Nanoliposomal Hydrogel for Treatment of Type 2 Diabetes Mellitus | AAPS PharmSciTech How GLP-1 Receptor Agonists Evolved

Fortunately, as the burden of diabetes and its related complications grows, newer therapeutic classes have emerged to help people manage this condition

Identification of a regulatory pathway of l-phenylalanine-induced GLP-1 secretion in the enteroendocrine L cells

Navigating the world of GLP-1 medications shouldn't be something you have to do alone

Ziyad Al-Aly, the studys lead author and a chief researcher at the VA St

For where these oral and higher-dose options sit among the candidates now in development, see the 2026 GLP-1 clinical pipeline, part of the broader GLP-1 and metabolic disease picture

Anecdotal evidence suggests that GLP-1 RAs may be beneficial in IBD treatment